SIBIONICS Announces Participation in the 17th International Conference on Advanced Technologies and Treatments for Diabetes
SIBIONICS, the world’s third-largest continuous glucose monitoring (CGM) brand, announced that it will participate in the International Diabetes Technology Exhibition at the 17th Symposium on Diabetes at the 17th Symposium on Diabetese International Conference on Advanced Technologies and Treatments for Diabetes…
VENUS REMEDIES BAGS APPROVAL TO MARKET MEROPENEM, ITS BLOCKBUSTER GENERIC DRUG, IN SPAIN
The pharmaceutical world is abuzz as Venus Remedies Limited secures marketing authorization for meropenem in Spain. A leader in research-based pharmaceuticals, Venus Remedies is setting new benchmarks in healthcare. Meropenem, part of the carbapenem class of antibiotics, is known for…
